0001209191-22-059702.txt : 20221205 0001209191-22-059702.hdr.sgml : 20221205 20221205163023 ACCESSION NUMBER: 0001209191-22-059702 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221202 FILED AS OF DATE: 20221205 DATE AS OF CHANGE: 20221205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ferrara Robert L CENTRAL INDEX KEY: 0001792987 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36304 FILM NUMBER: 221445316 MAIL ADDRESS: STREET 1: 257 SIMARANO DRIVE, SUITE 101 CITY: MARLBOROUGH STATE: MA ZIP: 01752 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Phio Pharmaceuticals Corp. CENTRAL INDEX KEY: 0001533040 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 257 SIMARANO DRIVE STREET 2: SUITE 101 CITY: MARLBOROUGH STATE: MA ZIP: 01752 BUSINESS PHONE: (508) 767-3861 MAIL ADDRESS: STREET 1: 257 SIMARANO DRIVE STREET 2: SUITE 101 CITY: MARLBOROUGH STATE: MA ZIP: 01752 FORMER COMPANY: FORMER CONFORMED NAME: RXi Pharmaceuticals Corp DATE OF NAME CHANGE: 20111019 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-12-02 0 0001533040 Phio Pharmaceuticals Corp. PHIO 0001792987 Ferrara Robert L C/O PHIO PHARMACEUTICALS CORP. 257 SIMARANO DRIVE, SUITE 101 MARLBOROUGH MA 01752 1 0 0 0 Common stock, $0.0001 par value 2022-12-02 4 P 0 5000 0.4082 A 30000 D This transaction was executed in multiple trades at prices ranging from $0.4075 to $0.4089. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Includes shares of common stock underlying unvested restricted stock units. Caitlin Kontulis, attorney-in-fact 2022-12-05